Trident Lifeline Ltd (543616)

BSE · Healthcare · Pharmaceuticals & Biotechnology · Pharmaceuticals

₹410.00

As of 30 Oct 2026 close.

Facts from reported results and exchange filings. Not investment advice.

Share price

Prices load here as you scroll to them.

Last close ₹410.00 on 30 Oct 2026. The share price traded between ₹229.95 and ₹442.00 (intraday) over the last 12 months.

The closes as a table

DateClose

Key figures

1-year range (intraday)

Last close ₹410.00

Low ₹229.95High ₹442.00

Market cap₹491 crorelast close × shares
P/E23.0on reported profit, last four quarters
Net profit₹21.00 crlast 12 months
Return on equity22.0%year to Mar 2026
EBITDA margin24%year to Mar 2026
Debt to equity0.38year to Mar 2026
Net margin17.6%year to Mar 2026
Dividend yieldnonelast 12 months

Price trend

Revenue and profit

RevenueNet profit₹ crore
050100150
YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue22324568102
Net profit4671318
EBITDA margin12%20%20%26%24%
Borrowings2361525

₹ crore. Over three years, compounded: revenue grew 47.2% a year, net profit grew 44.2% a year.

Recent filings

Questions about Trident Lifeline Ltd

What is Trident Lifeline Ltd's market value?

Trident Lifeline Ltd's market value is ₹491 crore as of 30 Oct 2026 close: the last close times the shares in issue. Its P/E is 23.0, the last close over earnings per share for the last four reported quarters.

Go further with 543616

Free to start: test a trading idea on 543616's real prices after costs, or open the full deep dive with ten years of numbers, red flags and management's record.

Same industry

The largest companies in the same industry (Pharmaceuticals), by market value.

Browse companies

The companies before and after this one, A to Z, and the lists it is in.

How these figures are worked out

The net profit for the last 12 months is the four latest reported quarters, so it can differ from the newest year's in the table below.